Dr. Dorothea Altschul is sub-investigator at The Valley Hospital for a multi-center clinical trial to study a device called the Penumbra 3D Separator. The instrument helps re-open arteries in patients in the midst of having a stroke.
There are two kinds of stroke: an ischemic stroke, where a blood vessel in the brain is blocked by a blood clot; and a hemorrhagic stroke, where blood supply is disrupted by bleeding in the brain.
The Penumbra 3D Separator Trial is looking at patients suffering from an acute ischemic stroke.
The device is being used within 8 hours of symptom onset at nearly 50 medical centers across the country. Each treated patient will be followed and assessed for 3 months.
The trial is necessary to obtain FDA approval of the device. Researchers are aiming for a December, 2014 end-date for this trial, at which time they hope to have treated more than 200 patients.
Learn more about this clinical trial here.
Learn more about Dr. Dorothea Altschul at her bio page here.
Related: Dr. Dorothea Altschul Heads Advanced Aneurysm Coiling Trial
